Contract Analytical Services

Thermo Fisher will add Olink to its Life Sciences Solutions business.

HCPs are major process-related impurities that must be monitored throughout biologics production for clearance.

Cormica’s first US Acquisition is intended to support to organic growth of TPM laboratories.

The company is investing more than $2 million in its analytical testing services and adding suppository manufacturing capabilities.

The company’s Itasca, Ill., facility will offer chemistry, manufacturing, and controls analytical testing support.

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.

Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.

By taking a strategic and evidence-based approach, companies can leverage the insights gained from stability studies to establish robust labeling.

MilliporeSigma has expanded its biosafety testing laboratories in Shanghai, China, with the completion of new lab space at its new €29 million (US$43 million) Biologics Testing Center.

The new centralized hub will provide advanced testing of nucleic acids, which is expected to simplify mRNA substance testing.

CN Bio and LifeNet Health LifeSciences have teamed up to provide direct access to a portfolio of highly characterized hepatic cells for the creation of advanced liver-on-a-chip assays.

Rentschler Biopharma’s ATMP business can now offer its full range of services for the clinical supply of AAV, including bioprocess and analytical development through to cGMP manufacturing at the Stevenage facility in the UK.

Illumina’s new solutions center in Bengaluru, India, will expand access to genomics in the country.

Laboratories are focusing on more automated processes while also trying to maintain an efficient, safe, and personalized experience with each analytical test.

Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.

Contract testing services demonstrate a major increase in the speed and efficiency of testing using new testing methods and technologies.

Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.

It is important to understand regulatory requirements and study challenges to develop and validate the appropriate methods for a bioanalytical study program at the clinical stage.

Through the Thermo Fisher Scientific and LabShares Newton partnership, life science startups can accelerate early-stage discovery and development with shared lab spaces.

PerkinElmer has expanded its genomics testing services with the launch of its ultrarapid whole genome sequencing.

Eurofins partners with PAMM to strengthen laboratory services for the Dutch healthcare system.

Scientists can work to overcome the challenges associated with protein characterization through empowering technologies.

Industry experts share their top outsourcing tips from both the perspective of companies offering outsourcing services as well as for companies looking to outsource.

Texcell North America’s new lab facility in Frederick, Md., will expand the CRO’s capabilities in R&D cell culture, viral clearance studies, and viral safety testing.

After a previously announced merger, Protagen Protein Services, BioAnalytix, and GeneWerk have formed a new CRO under the name ProtaGene.

Fujifilm Diosynth Biotechnologies' 89,000 square-foot expansion of its BioProcess Innovation Center in Research Triangle Park, N.C., will double its capacity to support process characterization.

The acquisition of Protein Metrics expands Insightful Science’s R&D solutions to include proteomics.

Particle analysis provides assurances of the quality and performance of the final dosage form in pharmaceutical development.

Particle analysis is a critical component of pharmaceutical development, providing assurances of the quality and performance of the final dosage form.